Brian J. Davis

Salvage prostate brachytherapy in radiorecurrent prostate cancer: An international Delphi consensus study

Interplay Between Duration of Androgen Deprivation Therapy and External Beam Radiotherapy With or Without a Brachytherapy Boost for Optimal Treatment of High-risk Prostate Cancer

NCCN Guidelines Insights: Prostate Cancer, Version 1.2021

Performance of a Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography–Derived Risk-Stratification Tool for High-risk and Very High-risk Prostate Cancer

Comparison of Multimodal Therapies and Outcomes Among Patients With High-Risk Prostate Cancer With Adverse Clinicopathologic Features

A Systematic Review and Meta-analysis of Local Salvage Therapies After Radiotherapy for Prostate Cancer (MASTER)

NRG Oncology Updated International Consensus Atlas on Pelvic Lymph Node Volumes for Intact and Postoperative Prostate Cancer

Development and Validation of a Clinical Prognostic Stage Group System for Nonmetastatic Prostate Cancer Using Disease-Specific Mortality Results From the International Staging Collaboration for Cancer of the Prostate

Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology

Radiotherapy for recurrent prostate cancer: 2018 Recommendations of the Australian and New Zealand Radiation Oncology Genito-Urinary group

ACR Appropriateness Criteria ® Post-treatment Follow-up Prostate Cancer

ACR Appropriateness Criteria ® Prostate Cancer—Pretreatment Detection, Surveillance, and Staging

ACR Appropriateness Criteria for external beam radiation therapy treatment planning for clinically localized prostate cancer, part II of II

ACR Appropriateness Criteria® Locally Advanced, High-Risk Prostate Cancer

Prostate Cancer, Version 1.2016

ACR Appropriateness Criteria® external beam radiation therapy treatment planning for clinically localized prostate cancer, part I of II

ACR appropriateness criteria: Permanent source brachytherapy for prostate cancer

ACR Appropriateness Criteria® Definitive External-Beam Irradiation in Stage T1 and T2 Prostate Cancer

Adjuvant and Salvage Radiation Therapy After Prostatectomy: American Society for Radiation Oncology/American Urological Association Guidelines